Kris MG - Search Results

1

Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives.

Lee JM, McNamee CJ, Toloza E, Negrao MV, Lin J, Shum E, Cummings AL, Kris MG, Sepesi B, Bara I, Kurtsikidze N, Schulze K, Ngiam C, Chaft JE. Lee JM, et al. Among authors: kris mg. J Thorac Oncol. 2023 Nov;18(11):1458-1477. doi: 10.1016/j.jtho.2023.07.006. Epub 2023 Jul 13. J Thorac Oncol. 2023. PMID: 37451404 Free PMC article. Review.

2

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.

Miller VA, Rigas JR, Francis PA, Grant SC, Pisters KM, Venkatraman ES, Woolley K, Heelan RT, Kris MG. Miller VA, et al. Among authors: kris mg. Cancer. 1995 Feb 15;75(4):968-72. doi: 10.1002/1097-0142(19950215)75:4<968::aid-cncr2820750411>3.0.co;2-y. Cancer. 1995. PMID: 7842417 Clinical Trial.

3

Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.

Pisters KM, Kris MG, Gralla RJ, Zaman MB, Heelan RT, Martini N. Pisters KM, et al. Among authors: kris mg. J Clin Oncol. 1993 Sep;11(9):1757-62. doi: 10.1200/JCO.1993.11.9.1757. J Clin Oncol. 1993. PMID: 8394881

4

Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.

Cleri LB, Kris MG, Tyson LB, Pisters KM, Clark RA, Gralla RJ. Cleri LB, et al. Among authors: kris mg. Cancer. 1995 Sep 1;76(5):774-8. doi: 10.1002/1097-0142(19950901)76:5<774::aid-cncr2820760510>3.0.co;2-5. Cancer. 1995. PMID: 8625179 Clinical Trial.

5

Chemotherapy for early stage non-small cell lung cancer.

Kris MG, Azzoli CG. Kris MG, et al. Lung Cancer. 2001 Dec;34 Suppl 3:S49-52. doi: 10.1016/s0169-5002(01)00372-5. Lung Cancer. 2001. PMID: 11740994 Review.

6

Trastuzumab in the treatment of non-small cell lung cancer.

Azzoli CG, Krug LM, Miller VA, Kris MG, Mass R. Azzoli CG, et al. Among authors: kris mg. Semin Oncol. 2002 Feb;29(1 Suppl 4):59-65. doi: 10.1053/sonc.2002.31526. Semin Oncol. 2002. PMID: 11894015 Review.

7

Long-term results of combined-modality therapy in resectable non-small-cell lung cancer.

Martin J, Ginsberg RJ, Venkatraman ES, Bains MS, Downey RJ, Korst RJ, Kris MG, Rusch VW. Martin J, et al. Among authors: kris mg. J Clin Oncol. 2002 Apr 15;20(8):1989-95. doi: 10.1200/JCO.2002.08.092. J Clin Oncol. 2002. PMID: 11956257

8

10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.

Krug LM, Azzoli CG, Kris MG, Miller VA, Khokhar NZ, Tong W, Ginsberg MS, Venkatraman E, Tyson L, Pizzo B, Baez V, Ng KK, Sirotnak FM. Krug LM, et al. Among authors: kris mg. Clin Cancer Res. 2003 Jun;9(6):2072-8. Clin Cancer Res. 2003. PMID: 12796370 Clinical Trial.

9

Single-agent docetaxel (Taxotere) in the treatment of advanced non small-cell lung cancer: clinical concepts and commentary.

Laurie SA, Kris MG. Laurie SA, et al. Among authors: kris mg. Clin Lung Cancer. 2000 Apr;1 Suppl 1:S5-9. doi: 10.3816/clc.2000.s.001. Clin Lung Cancer. 2000. PMID: 14725735

10

Practical management of patients with non-small-cell lung cancer treated with gefitinib.

Shah NT, Kris MG, Pao W, Tyson LB, Pizzo BM, Heinemann MH, Ben-Porat L, Sachs DL, Heelan RT, Miller VA. Shah NT, et al. Among authors: kris mg. J Clin Oncol. 2005 Jan 1;23(1):165-74. doi: 10.1200/JCO.2005.04.057. Epub 2004 Nov 22. J Clin Oncol. 2005. PMID: 15557594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

495 results

Search Page